Evotec SE EVT
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Evotec SE is a leading life science company specializing in drug discovery and development for pharmaceutical and biotechnology partners. Founded in 1993 in Hamburg, Germany, it operates through two key segments: EVT Execute, which delivers integrated drug discovery solutions on a fee-for-service basis or via milestone…
SectorHealthcare
ExchangeXETR
IndustryDrug Manufacturers - Specialty & Generic
CountryGermany
Employees4,526
TickerEVT
Statistics
Market Cap$975.3M
Revenue (TTM)$839.1M
Net Income—
Net Margin—
EPS—
P/E-8.10
P/S1.16
P/B1.24
EV/EBITDA-47.30
ROE-24.1%
Dividend Yield—
Price$5.49
Data: Twelve Data · Revenue = mcap / P/S